[Malignant lymphoma. Physiopathology and treatment: 4. NK/T cell lymphoma].
Yamaguchi
Motoko
M
D003131:Combined Modality Therapy; D006801:Humans; D054391:Lymphoma, Extranodal NK-T-Cell / Q000473:pathology / Q000628:therapy*; D009669:Nose Neoplasms / Q000473:pathology / Q000628:therapy*